GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Swiss Helvetia Fund Inc (NYSE:SWZ) » Definitions » Intrinsic Value: Projected FCF

Swiss Helvetia Fund (Swiss Helvetia Fund) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Swiss Helvetia Fund Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-06), Swiss Helvetia Fund's Intrinsic Value: Projected FCF is $0.00. The stock price of Swiss Helvetia Fund is $8.27. Therefore, Swiss Helvetia Fund's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Swiss Helvetia Fund's Intrinsic Value: Projected FCF or its related term are showing as below:

SWZ's Price-to-Projected-FCF is not ranked *
in the Asset Management industry.
Industry Median: 0.94
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Swiss Helvetia Fund Intrinsic Value: Projected FCF Historical Data

The historical data trend for Swiss Helvetia Fund's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swiss Helvetia Fund Intrinsic Value: Projected FCF Chart

Swiss Helvetia Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Swiss Helvetia Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Swiss Helvetia Fund's Intrinsic Value: Projected FCF

For the Asset Management subindustry, Swiss Helvetia Fund's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swiss Helvetia Fund's Price-to-Projected-FCF Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Swiss Helvetia Fund's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Swiss Helvetia Fund's Price-to-Projected-FCF falls into.



Swiss Helvetia Fund Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Swiss Helvetia Fund  (NYSE:SWZ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Swiss Helvetia Fund's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=8.27/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Swiss Helvetia Fund Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Swiss Helvetia Fund's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Swiss Helvetia Fund (Swiss Helvetia Fund) Business Description

Traded in Other Exchanges
N/A
Address
C/o U.S. Bank Global Fund Services, 615 East Michigan Street, Milwaukee, WI, USA, 53202
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, and retail.
Executives
Andrew Dakos director 250 PEHLE AVE., SUITE 708, SADDLE BROOK NJ 07663
Phillip Goldstein director 60 HERITAGE DRIVE, PLEASANTVILLE NY 10570
Moritz A Sell director C/O USBANCORP FUND SERVICES, 777 E WISCONSIN AVE., MILWAUKEE WI 53202
Gerald Hellerman director 5431 NW 21ST AVE., BOCA RATON FL 33496
Stephanie Darling officer: Chief Compliance Officer 250 PEHLE AVE., SUITE 708, SADDLE BROOK NJ 07663
Rajeev P Das officer: Secretary 250 PEHLE AVE., SUITE 708, SADDLE BROOK NJ 07663
Thomas Antonucci officer: Chief Financial Officer 250 PEHLE AVE. SUITE 708, SADDLE BROOK NJ 07663
Richard Dayan director C/O IMPERIAL HOLDINGS, INC., 701 PARK OF COMMERCE BLVD., SUITE 301, BOCA RATON FL 33487
David Bock director C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Jean Hoysradt director C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Samuel B Witt director STATFESIDE ASSOCIATES INC, 2300 CLARENDON BLVD STE 407, ARLINGTON VA 22201
Fred J Ricciardi director 60 STATE STREET, BOSTON MA 02109
Reid B Adams officer: Chf. Legal Officer & Secretary SCHRODER INVEST. MGMT. NORTH AMERICA INC, 875 THIRD AVENUE, 22ND FLOOR, NEW YORK NY 10022
Jean-marc Boillat director LES GADRAS, VILLENEUVE DE DURAS I0 47120
Calhoun Joseph S Iii director C/O SCHRODERS, 875 THIRD AVENUE, 22ND FLOOR, NEW YORK NY 10022